US Pre-Market SEC Filings Roundup — April 20, 2026

20-04-2026

GTII Receivership Estate, assignee of MSC Capital Advisors LLC, converted $42,062.13 of principal and accrued interest from defaulted AURI convertible promissory notes into 841,242,529 shares of AURI common stock at $0.00005 per share (75% discount to $0.0002 market price), exhausting all 841,242,529 available authorized unissued shares and representing 8.41% of post-conversion outstanding shares. This partially reduces the $125,000 original principal but leaves $103,515.96 in remaining debt, with both notes in default. The estate demands AURI increase authorized shares to reserve 4.5x coverage for full conversion and fully disclose the notes in OTC Markets filings.

• ·AURI Note 1 maturity: Oct 18, 2025 (past due, in default); AURI Note 2 maturity: Mar 25, 2026 (past due, in default)
• ·Conversion date: April 8, 2026; Market price (April 7, 2026): $0.0002; Conversion price: $0.00005
• ·Shares must be issued within 3 business days or incur $500/day Fail to Deliver Fee
• ·Beneficial ownership post-conversion: 8.41% (under 9.99% limitation)
• ·AURI subject to OTC Markets Alternative Reporting Standard; required to disclose notes, conversion, and holder details in next filing

20-04-2026

QXO, Inc. announced a definitive agreement to acquire TopBuild Corp. for approximately $17 billion in a deal valuing each TopBuild share at $505, a 19.8% premium to the 60-day VWAP and 23.1% to the April 17, 2026 closing price, expected to close in Q3 2026 and be immediately accretive to earnings. The combination will create the second largest publicly traded building products distributor in North America with over $18 billion in combined revenue, more than $2 billion in combined adjusted EBITDA, 28,000 employees, 1,150 locations, and leadership positions including #1 in insulation and #2 in roofing within a $300 billion addressable market. QXO anticipates $300 million in synergies by 2030, following its recent $2.25 billion acquisition of Kodiak Building Partners on April 1, 2026.

• ·TopBuild management guidance: $9-10B annual revenue and $1.7-2.0B adjusted EBITDA by 2030; cumulative FCF $4.2-5.0B from 2026-2030.
• ·QXO board to expand to include one TopBuild nominee.
• ·Transaction consideration: 45% cash / 55% QXO stock, with proration and potential adjustment.
• ·Advisors: Morgan Stanley (lead for QXO), Barclays, Wells Fargo Securities; Goldman Sachs, RBC Capital Markets (for TopBuild).

20-04-2026

ClimateRock, a blank check company, is convening an extraordinary general meeting on May 1, 2026, to approve the Fifth Extension Amendment Proposal, extending the business combination deadline from May 2, 2026, to November 2, 2026, to facilitate the ongoing GreenRock Business Combination. The Adjournment Proposal allows for further solicitation if needed. Without extension approval, the company faces liquidation risk, ceasing operations and redeeming public shares.

• ·Record Date: April 10, 2026
• ·Meeting location: 1345 Avenue of the Americas, 11th Floor, New York, New York 10105
• ·Previous extensions: From May 2, 2023 (initial 12 months post-IPO on May 2, 2022) through paid extensions to November 2, 2023; then to May 2, 2024; May 2, 2025; November 2, 2025; and May 2, 2026
• ·Fifth Extension Amendment requires 2/3 affirmative vote; Adjournment requires simple majority
• ·Public shareholders may redeem shares in connection with the extension regardless of vote

20-04-2026

ACI Worldwide, Inc. (ACIW) has filed definitive additional proxy materials (DEFA14A) for its Annual Meeting of Stockholders on June 2, 2026, at 10:00 AM ET, held virtually via www.proxydocs.com/ACIW. Key proposals include electing nine directors to serve until the 2027 annual meeting, ratifying Deloitte & Touche LLP as the independent auditor for 2026, and an advisory vote to approve named executive officer compensation. Stockholders of record as of April 8, 2026, can access full materials online and must request paper copies by May 23, 2026.

• ·Filing date: April 20, 2026
• ·Record date: April 8, 2026
• ·Paper material request deadline: May 23, 2026
• ·Proxy voting websites: www.proxydocs.com/ACIW, www.investorelections.com/ACIW
• ·Proxy phone: 1-866-648-8133

20-04-2026

Bright Horizons Family Solutions Inc. (BFAM) filed its DEF 14A Proxy Statement on April 20, 2026, for the virtual 2026 Annual Meeting of Shareholders on June 3, 2026, at 8:00 a.m. ET. Shareholders of record as of April 8, 2026, will vote on electing six director nominees for one-year terms, approving on an advisory basis the 2025 compensation paid to named executive officers, and ratifying Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

• ·Virtual meeting accessible at www.virtualshareholdermeeting.com/BFAM2026; requires 16-digit control number for admission.
• ·Proxy materials and 2025 Annual Report on Form 10-K available at www.proxyvote.com or investors.brighthorizons.com.
• ·Includes sections on director nominees, executive compensation (including Pay versus Performance), audit matters, and corporate governance.

20-04-2026

SOLAI Ltd's annual report shows revenues declining sharply to $23,000 thousand in 2025 from $32,922 thousand in 2024 (-30% YoY) and $43,101 thousand in 2023 (-47% from 2023), with cryptocurrency mining plummeting 61% YoY to $6,670 thousand while data center revenues were nearly flat at +3% to $16,330 thousand. Net loss attributable to SOLAI Limited widened to $33,877 thousand in 2025 from a $12,073 thousand profit in 2024 (driven by $18,927 thousand gain from discontinued operations), with continuing operations posting a $33,877 thousand loss versus $6,854 thousand loss in 2024. Cash and equivalents ended 2025 at $1,420 thousand, down from $1,810 thousand.

• ·Impairment of property and equipment: $8,764 thousand in 2025
• ·Impairment of intangible assets: $1,405 thousand in 2025
• ·Net cash used in operating activities: $26,929 thousand in 2025 (improved from $32,743 thousand in 2024)
• ·Gain on disposal of discontinued operations: $18,687 thousand in 2024
• ·ADS: Each represents 100 Class A ordinary shares, traded on NYSE
• ·Adjusted non-GAAP net loss from continuing operations: $25,103 thousand in 2025

20-04-2026

Perspective Therapeutics, Inc. posted a poster on its website on April 18, 2026, presenting interim results from its Phase 1/2a clinical trial of [212Pb]VMT-α-NET for unresectable or metastatic somatostatin receptor subtype 2-expressing neuroendocrine tumors at the AACR 2026 Annual Meeting (April 17-22, 2026, San Diego, CA). The company issued a related press release on April 20, 2026, and updated its corporate presentation on April 18, 2026. No specific quantitative outcomes from the interim results are detailed in the filing text.

• ·AACR 2026: American Association for Cancer Research Annual Meeting, April 17-22, 2026, San Diego, CA
• ·Exhibits: 99.1 (AACR Poster), 99.2 (Press Release dated April 20, 2026), 99.3 (Investor Presentation)

20-04-2026

Investar Holding Corporation reported strong Q1 2026 net income available to common shareholders of $11.5 million ($0.77 per diluted share), up from $5.4 million ($0.51) in Q4 2025, driven by the January 1, 2026 acquisition of Wichita Falls Bancshares, Inc. (WFB) which added $891.8 million in loans (total $3.07 billion, +41.0% QoQ) and $882.6 million in deposits (total $3.23 billion, +37.6% QoQ), alongside net interest margin expansion to 3.59% (+39 bps QoQ). However, nonperforming loans increased to $20.3 million (0.66% of loans) from $9.3 million (0.43%) QoQ, tangible book value per share declined 3.0% to $22.72, and while efficiency ratio improved to 64.08%, credit quality showed deterioration.

• ·Core diluted EPS $0.87 in Q1 2026 vs $0.58 Q4 2025.
• ·Return on average assets 1.25% Q1 2026 vs 0.83% Q4 2025.
• ·Efficiency ratio 64.08% Q1 2026 vs 69.34% Q4 2025.
• ·Yield on loan portfolio 6.28% Q1 2026 vs 5.99% Q4 2025.
• ·Cost of funds 2.94% Q1 2026 (-4 bps QoQ); cost of deposits 2.85% (-6 bps QoQ).
• ·Business lending portfolio $1.17B (+10.6% QoQ).
• ·Reversal of credit losses $2.1M in Q1 2026.
• ·Noninterest-bearing deposits $640.1M (19.8% of total); brokered time deposits declined 50.4% QoQ to $101.2M.
• ·Book value per share $27.97 (+1.2% QoQ).

20-04-2026

News Corporation disclosed via 8-K the provision of daily information to the Australian Securities Exchange (ASX) regarding its ongoing $1 billion stock repurchase program authorizing purchases of Class A (NWSA) and Class B (NWS) common stock. Exhibits 99.1 and 99.2 contain the specific ASX disclosures for the dates noted therein, as required under ASX rules, with no aggregate repurchase activity quantified in the filing. The disclosures note potential forward-looking intent to repurchase shares subject to market conditions.

• ·Date of earliest event reported: April 17, 2026
• ·Filing date: April 20, 2026
• ·Securities: Class A Common Stock (NWSA, par value $0.01), Class B Common Stock (NWS, par value $0.01), both on Nasdaq Global Select Market

20-04-2026

Principal Financial Group, Inc. reported preliminary assets under management (AUM) of $770.2 billion as of March 31, 2026, with $578.0 billion managed by Principal Asset Management - Investment Management and $159.6 billion by Principal Asset Management - International Pension. For the quarter ended March 31, 2026, market performance, foreign currency translation, and other items resulted in a 1.2% negative impact relative to beginning period AUM. The disclosure highlights exposures to small/mid-cap and international equities, high yield and preferred securities in fixed income, and emerging market exchange rates amid market dislocations.

• ·AUM figures will be consistent with the format in the Company's financial supplement for quarter ended March 31, 2026, posted on or about April 23, 2026.
• ·Filing intended to satisfy Regulation FD prior to quarterly earnings release.

20-04-2026

Calavo Growers, Inc. announced that the HSR Act waiting period for its proposed merger with Mission Produce, Inc. expired on April 17, 2026, satisfying one key regulatory condition. However, the transaction remains subject to Calavo shareholder approval, Mission Produce stockholder approval, and Mexico antitrust clearance, with potential risks of delays or failure to meet these conditions. The parties anticipate closing in the fiscal quarter ending July 31, 2026, if all conditions are satisfied.

• ·Merger Agreement entered on January 14, 2026.
• ·Registration Statement on Form S-4 filed March 9, 2026; Amendment No. 1 on March 18, 2026; declared effective March 20, 2026.
• ·Joint Proxy Statement/Prospectus mailing commenced on or about March 25, 2026.

20-04-2026

FACTORIAL MANAGEMENT Ltd, a Hong Kong-based investment manager, filed a 13F-HR report disclosing its holdings as of March 31, 2026, totaling $3,824,437 across three positions. The portfolio consists of notes from Alibaba Group Holding Ltd ($1,387,835 par value $1,000,000) and Trip.com Group Ltd ($1,036,853 par value $1,000,000), plus 56,260 shares of HDFC Bank Ltd sponsored ADS valued at $1,399,749. No prior period comparisons or changes in holdings were detailed in the filing.

• ·Filing covers period ending 03-31-2026, filed 04-20-2026.
• ·All positions held with sole investment discretion.
• ·Filer address: Unit B 12/F On Hing Building, 1 On Hing Terrace, Central, Hong Kong.

20-04-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed a Form 8-K on April 20, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Exhibits), announcing the issuance of a press release titled 'AITX Shares Fiscal 2027 Revenue Targets and Market Opportunity.' The press release is furnished as Exhibit 99.1. No specific financial figures, targets, or performance metrics were detailed in the filing itself.

20-04-2026

Huntsman Corporation filed additional definitive proxy materials on April 20, 2026, defending the re-election of director José Antonio Muñoz Barcelo at the April 29, 2026 Annual Meeting, despite ISS and Glass Lewis recommending against him due to 69% attendance in 2025 (below 75% threshold, missing two Board and two committee meetings). The Board highlights these absences stemmed from high-profile conflicts including meetings with President Trump on tariffs and the APEC CEO Summit (relevant as Asia-Pacific generated nearly 30% of Huntsman's 2025 revenue), notes his strong prior record (93% average 2022-2024, 100% in 2024), and emphasizes his invaluable expertise as CEO of Hyundai Motor Company (over $100B revenue). The Board unanimously recommends voting FOR all director nominees, including Mr. Muñoz.

• ·Mr. Muñoz missed Board meeting on April 30, 2025 (attended committees prior day) due to meeting with President Trump on tariffs impacting Huntsman.
• ·Mr. Muñoz missed Board, Compensation, and Sustainability meetings on October 29-30, 2025 due to APEC CEO Summit in South Korea discussing U.S.-Korea trade, tariffs, and automotive production.
• ·Proxy solicitor contact: Innisfree M&A Incorporated at (877) 717-3936.

20-04-2026

QXO, Inc. announced on April 19, 2026, that it has entered into an agreement to acquire TopBuild Corp., the largest distributor and installer of insulation and related building products in North America, with the transaction expected to close in Q3 2026. Post-acquisition, QXO anticipates over $18 billion in company revenue and more than $2 billion in adjusted EBITDA, positioning it as the second largest publicly traded building products distributor and advancing its goal of becoming a $50 billion company. However, the deal faces risks including potential failure to close due to shareholder approvals, financing challenges, regulatory actions, or termination fees.

• ·TopBuild founded in 2015 and headquartered in Daytona Beach, Florida.
• ·Post-acquisition, QXO to hold #1 position in insulation, #2 in roofing, #1 in waterproofing.
• ·QXO expects to file Form S-4 registration statement with joint proxy statement/prospectus.

20-04-2026

American Airlines Group Inc. issued a statement on April 17, 2026, furnished as Exhibit 99.1 under Item 7.01 Regulation FD Disclosure in its 8-K filing dated April 20, 2026. The disclosure is not deemed 'filed' and includes standard forward-looking statement disclaimers referencing risks from the latest 10-K. The filing was signed by Anthony J. Richmond, Executive Vice President, Corporate Affairs and Chief Legal Officer.

20-04-2026

Constellation Energy Corporation (CEG) and Constellation Energy Generation, LLC completed the acquisition of Calpine Corporation on January 7, 2026, pursuant to a Merger Agreement dated January 10, 2025, converting Calpine into Calpine LLC as an indirect wholly-owned subsidiary. This 8-K/A, filed April 17, 2026, amends the original March 20, 2026 filing solely to update the Report of Independent Auditors by PricewaterhouseCoopers LLP with a conformed signature and provide a dated consent. Exhibits include Calpine's audited consolidated financial statements as of and for the years ended December 31, 2025, 2024, and 2023 (Exhibit 99.1) and unaudited pro forma condensed combined financial statements of CEG Parent and Constellation as of and for the year ended December 31, 2025 (Exhibit 99.2).

• ·Merger Agreement dated January 10, 2025.
• ·Original 8-K filed March 20, 2026.
• ·Auditor consents: Deloitte & Touche LLP (23.1), PricewaterhouseCoopers LLP (23.2).

20-04-2026

Enveric Biosciences, Inc. (ENVB) announced a private placement priced at-the-market under Nasdaq rules, issuing 2,222,223 shares of common stock (or pre-funded warrants) at $2.25 per share along with Series I and short-term Series J warrants to purchase up to 2,222,223 shares each at $2.00 exercise price, expected to yield $5 million upfront gross proceeds. Potential additional gross proceeds of approximately $8.9 million could result if warrants are fully exercised, for total up to $13.9 million, to be used for product development, working capital, and general corporate purposes. H.C. Wainwright & Co. serves as exclusive placement agent; closing expected on or about April 17, 2026, subject to customary conditions, with no assurance of warrant exercises.

• ·Purchase price: $2.25 per share (or pre-funded warrant)
• ·Warrant exercise price: $2.00 per share, immediately exercisable
• ·Series I warrants expire five years after Resale Registration Statement effective date
• ·Series J warrants expire eighteen months after Resale Registration Statement effective date
• ·Announcement date: April 16, 2026; Filing date: April 20, 2026

20-04-2026

Hydrofarm Holdings Group, Inc. (HYFM) dismissed Deloitte & Touche LLP as its independent registered public accounting firm effective April 14, 2026, and engaged CBIZ CPAs P.C. for the fiscal year ending December 31, 2026, following a selection process by the Audit Committee. The change resulted from no disagreements on accounting principles, financial disclosures, auditing scope, or reportable events during fiscal years 2024 and 2025 or the interim period through April 14, 2026. Deloitte's audit reports for those years were unqualified, and Deloitte provided a letter agreeing with the company's disclosures.

• ·Common Stock: $0.0001 par value per share, traded as HYFM on Nasdaq Stock Market LLC.
• ·No prior consultations with CBIZ CPAs on accounting, auditing, or reporting matters.
• ·Deloitte letter filed as Exhibit 16.1.

20-04-2026

AiRWA Inc. closed its acquisition of all share capital of Aberfeldy Holdings Limited, a Seychelles holding company owning 100% of 26 Rafael Sdn. Bhd., for $140,000,000 payable in cash on January 30, 2026. This Form 8-K/A amends the original filing to include audited financial statements of Rafael for the years ended April 30, 2025 and 2024, unaudited financial statements for the nine months ended January 31, 2026, and unaudited pro forma combined financial statements of the Company for the year ended April 30, 2025 and nine months ended January 31, 2026. No specific financial performance metrics or period-over-period comparisons are provided in the filing text.

• ·Securities registered: Common Stock, $0.001 par value, trading as YYAI on Nasdaq Capital Market.
• ·Audited financial statements of Rafael attached as Exhibit 99.1.
• ·Unaudited pro forma combined financial statements attached as Exhibit 99.3.
• ·Consent of Enrome LLP attached as Exhibit 23.1.

20-04-2026

Generation Income Properties, L.P. amended the LLC agreement for GIPIA 1220 S. Duff Avenue, LLC (Iowa SPE), simplifying JCWC Funding LLC's preferred return on its $3,080,000 investment from 8.0% annual (6.5% cash + 1.5% accrued) to 6.5% cash-only, with automatic extensions up to August 23, 2029, and IRR redemption hurdles of 9.5%-12.5%. However, Nasdaq granted only a limited extension to August 4, 2026, to regain compliance with the $2,500,000 stockholders' equity requirement, with no assurance of success. The Iowa SPE owns a 30,465 sq ft retail property fully leased to Best Buy under a triple net lease, originally funded by JCWC preferred equity and a $2,495,000 Valley National Bank loan.

• ·Iowa SPE formed to own, operate, and manage the Ames Property at 1220 South Duff Avenue, Ames, Iowa 50010.
• ·Nasdaq hearing held March 24, 2026; Panel decision April 17, 2026.
• ·Redemption notice must be delivered no later than 180 days prior to extension period end; Iowa SPE redemption election from August 23, 2026 with 180-360 days notice.
• ·JCWC protective rights include replacing managing member for uncured senior loan defaults or Preferred Return payment failures.

20-04-2026

Stabilis Solutions, Inc. entered into an Equity Distribution Agreement dated April 17, 2026, with Johnson Rice & Company LLC, which is incorporated by reference into a Registration Statement. The filing includes an opinion from attorney Joel Bernstein on the legality of the common stock shares issuable under the agreement (Exhibit 5.1) and related consents. No financial performance metrics or period comparisons are disclosed.

• ·Filing includes Exhibits: 1.1 (Equity Distribution Agreement), 5.1 (Legal Opinion), 23.1 (Consent), and 104 (Inline XBRL Cover Page).

20-04-2026

Prelude Therapeutics Incorporated announced new preclinical data for its lead development candidate PRT13722 at the AACR Annual Meeting 2026 on April 20, 2026, highlighting its potential as a first-in-class, orally bioavailable KAT6A degrader with superior disruption of KAT6A pathways, durable complete tumor regressions in HR+/HER2- breast cancer xenograft models as monotherapy, and synergy with endocrine therapy, CDK4/6 inhibitors, and PI3Kα inhibitors in sensitive, mutated, and resistant models. PRT13722 also demonstrates an improved preclinical hematological safety profile compared to prifetrastat. The program remains on track for an IND filing in mid-2026 and Phase 1 study initiation in the second half of 2026, pending clearance.

• ·PRT13722 maintains monotherapy and combination activity across HR+ BC models, including estrogen receptor 1 mutated and acquired therapy-resistant cancer cells.

20-04-2026

Blue Chip Capital Group Inc. reported zero revenues for both the three and nine months ended February 28, 2026, remaining flat YoY at $0. The company posted a significantly widened net loss of $17,836,235 for the nine months ended February 28, 2026, compared to $1,504,505 in the prior year, driven by massive inducement expenses of $10,176,450 and stock-based compensation of $5,885,611. Cash depleted to $0 from $393, total liabilities surged to $1,800,272 from $609,756, and stockholders' deficit deepened to $(1,711,682) from $(520,773), with common shares outstanding increasing to 97,806,900 from 86,289,400 due to issuances for notes and services.

• ·Convertible notes payable net: $1,080,242 as of February 28, 2026 (up from $447,486)
• ·Accounts Payable-Related Party: $268,360 as of February 28, 2026 (up from $105,000)
• ·Accrued interest payable: $126,978 as of February 28, 2026 (up from $22,030)
• ·Weighted average common shares basic and diluted nine months: 93,261,039 in 2026 vs 81,111,644 in 2025
• ·Net cash used in operating activities nine months: $955,393 in 2026 vs $317,993 in 2025
• ·Warrants outstanding: 6,370,000 at average exercise price $1.27 as of February 28, 2026

20-04-2026

USA Rare Earth, Inc. (USAR) entered into a definitive Agreement and Plan of Merger on April 19, 2026, to acquire SVRE Holdings Ltd. for $300,000,000 in cash and 126,849,307 USAR shares, with the transaction expected to close no later than Q3 2026 subject to approvals including USAR stockholder vote and HSR clearance. The deal includes automatic exercise of DFC and SVRE shareholder warrants, treatment of equity awards, and appointments of Sir Mick Davis and Thrasyvoulos Moraitis to USAR's board. Termination fees of $75,000,000 or $25,000,000 apply if stockholder approval fails, depending on board recommendation changes.

• ·Merger requires USAR Stockholder Approval by majority vote, Company Shareholders' consent, HSR waiting period expiration, and consents/amendments under existing financing (DFC Retained Finance Agreement, USAR Parent Loan Agreement).
• ·SVRE equity awards (RSUs, SARs, non-performance options) fully vest and convert to cash and stock portions; Performance-Vesting Options convert to Substituted RSU Awards vesting on continued service with acceleration on qualifying termination.
• ·USAR obtained representation and warranty insurance covering SVRE breaches.

20-04-2026

Monopar Therapeutics Inc. announced new analyses from the Phase 3 FoCus trial of ALXN1840 (tiomilibdate choline), demonstrating greater neurologic benefit versus standard of care in Wilson disease patients with neurologic symptoms at baseline. The data was presented at the American Academy of Neurology (AAN) Annual Meeting on April 18-22, 2026, via a press release dated April 19, 2026. No negative or flat metrics were reported in the filing.

• ·Filing date: April 20, 2026
• ·Date of earliest event: April 19, 2026
• ·Exhibits include Press Release (99.1) and Poster Presentation (99.2)

20-04-2026

DAQO New Energy Corp. reported FY2025 revenues of $665.4 million, a 35% YoY decline from $1,029.1 million in 2024, amid falling polysilicon sales volumes totaling 126,707 MT. Gross loss narrowed to $137.9 million from $212.9 million, and net loss attributable to ordinary shareholders improved to $170.5 million from $345.2 million, bolstered by positive operating cash flow of $49.7 million versus a $435.4 million outflow in 2024. The company ended 2025 with strong liquidity, including $980.3 million in cash, cash equivalents and restricted cash, $1,035.6 million in fixed-term deposits, and $2,110.3 million in net current assets with no bank borrowings, though it plans no material capex due to adverse market conditions.

• ·No bank borrowings as of December 31, 2025.
• ·No material capital expenditures expected in the near future due to adverse market conditions.
• ·Baotou City strategic cooperation includes polysilicon for solar (200,000 MT total capacity), semiconductor (21,000 MT), silicon metal (300,000 MT), and silicone (200,000 MT) projects.

20-04-2026

Tuniu Corp's FY2025 revenues increased 12.5% YoY to RMB 577,974 thousand from RMB 513,622 thousand in FY2024, continuing 16.4% growth from RMB 441,270 thousand in FY2023. However, net income attributable to Tuniu Corporation fell 59.7% to RMB 31,125 thousand from RMB 77,174 thousand, while total assets declined 16.2% to RMB 1,599,983 thousand and shareholders' equity dipped 4.7% to RMB 1,030,301 thousand. Cash and cash equivalents dropped sharply 55.4% to RMB 207,228 thousand amid higher short-term investments.

• ·Hypothetical tax scenario: 25% statutory rate and 10% withholding tax on dividends to parent, netting 67.5% distribution.
• ·Certain subsidiaries qualify for 15% preferential tax rate in China.
• ·Lower 5% withholding possible under tax treaties (e.g., Hong Kong).

20-04-2026

Piermont Valley Acquisition Corp., a SPAC, entered into a merger agreement on April 17, 2026, with Tigerless Health, Inc., an insurtech company, involving mergers into Pubco (Tigerless AI Holdings Inc.), with closing expected in the second half of 2026 subject to stockholder approvals, regulatory conditions, and Nasdaq listing. Upon closing, former Tigerless stockholders will receive 5,600,000 Pubco Class A shares and 22,400,000 Class B shares, while Piermont stockholders get 5,952,886 Class A shares (assuming no redemptions); no immediate financial declines noted, but earnout shares up to $100M are contingent on post-closing milestones like >30% YoY revenue growth or >3% gross margin improvement.

• ·Termination possible if not closed by September 30, 2026 (extendable to December 31, 2026 if SEC delays Registration Statement)
• ·Pubco Class A common stock to be listed on Nasdaq; Class B not publicly traded
• ·Earn-out periods tested independently; no carryforward of unearned amounts
• ·Tigerless founded in 2018, headquartered in New York City

20-04-2026

Infinity Natural Resources, Inc. reported preliminary Q1 2026 derivative impacts, including realized losses of $18 million from settled contracts and non-cash unrealized losses of $47 million on open positions, resulting in total estimated derivative losses of $65 million. The portfolio shows mixed fair values, with positive marks on natural gas fixed price swaps ($30.4 million) offset by losses on oil swaps ($42.3 million), collars ($1.2 million), basis swaps ($4.6 million), and NGLs ($6.2 million). These figures are unaudited and subject to change upon final 10-Q filing.

• ·Oil swaps volume: 3,880 MBbls across 2026-2029
• ·Natural gas fixed price swaps volume: 196,842,000 MMBtu across 2026-2031
• ·Natural gas basis swaps volume: 107,530,250 MMBtu across 2026-2029
• ·NGL swaps volume: 3,154,571 Mbbls across 2026-2028
• ·Preliminary unaudited information for quarter ended March 31, 2026, to be finalized in Form 10-Q

20-04-2026

Cleveland-Cliffs reported first-quarter 2026 revenues of $4.9 billion, up approximately 6% YoY from $4.6 billion and 14% QoQ from $4.3 billion, driven by steel shipments of 4.1 million net tons (up 9% QoQ but down slightly 1% YoY) and higher average selling prices of $1,048 per net ton (up 7% YoY and 6% QoQ). The company posted a GAAP net loss of $229 million ($0.42 per diluted share), improved from $486 million YoY and $235 million QoQ, with Adjusted EBITDA of $95 million (versus losses of $179 million YoY and $21 million QoQ) inclusive of an $80 million one-time energy cost impact from extreme cold weather. Liquidity remained strong at $3.1 billion as of March 31, 2026.

• ·Q1 2026 steel product sales mix: 44% hot-rolled, 29% coated, 15% cold-rolled, 5% plate, 3% stainless and electrical, 4% other including slabs
• ·Steelmaking sales breakdown: 31% to distributors and converters ($1.5B), 29% to infrastructure and manufacturing ($1.4B), 29% to automotive ($1.4B), 11% to steel producers ($552M)
• ·FY2026 outlook maintained: steel shipments 16.5-17.0 million net tons, capex ~$700M, SG&A ~$575M, DDA ~$1.1B, cash pension/OPEB ~$125M
• ·Conference call scheduled for April 20, 2026, at 8:30 a.m. ET

20-04-2026

U.S. GoldMining Inc. issued a press release on April 20, 2026, announcing the mobilization of its 2026 Exploration Program at the Whistler Project in Alaska, emphasizing potential district-scale upside. The disclosure was made pursuant to Regulation FD under Items 7.01 and 9.01 of Form 8-K, with the press release furnished as Exhibit 99.1.

20-04-2026

Thermon Group Holdings, Inc. (NYSE: THR) released an update on April 20, 2026, regarding its liquid load bank solutions serving the data center market. The press release is available on the Company's investor relations website at https://ir.thermon.com. This disclosure is furnished under Item 7.01 of Form 8-K and not considered filed.

20-04-2026

Sable Offshore Corp. issued a press release and posted presentation materials on its website announcing corporate updates on current operational, legal, and financial matters. The disclosures include forward-looking statements on recommencing full production of the SYU assets and refinancing the Senior Secured Term Loan, subject to risks such as costs, timing, financing availability, and regulatory uncertainties. No specific financial metrics or period-over-period comparisons were detailed in the filing.

• ·Filing date: April 20, 2026
• ·SEC Items: 7.01 (Regulation FD Disclosure), 9.01 (Financial Statements and Exhibits)
• ·Exhibits: 99.1 (Press Release), 99.2 (Presentation Materials)

20-04-2026

OP Asset Management Ltd filed Form 13F-HR on April 20, 2026, disclosing its US equity holdings as of March 31, 2025, with all positions held on a sole discretionary basis. Top holdings include Apple Inc. at $375808863 (1,691,842 shares), Amazon.com Inc. at $213692231 (1,123,159 shares), Alphabet Inc. CAP STK CL A at $101349355 (655,389 shares), and Alphabet Inc. CAP STK CL C at $92251472 (590,485 shares). The portfolio spans hundreds of US-listed stocks across sectors like technology, financials, and consumer goods.

• ·Filing period end date: 20250331
• ·All holdings reported as SH SOLE with no other managers or voting authority
• ·Filer CIK: 0002097005
• ·Filer located at Gebhardsinaukio 1, Helsinki H9 00510, Finland

20-04-2026

X-Energy, Inc. filed an S-1/A registration statement on April 20, 2026, in connection with its initial public offering, disclosing 2025 compensation for named executive officers including CEO J. Clay Sell ($10,497,682 total, driven by $9,188,142 in stock awards), CFO Daniel Gross ($6,376,995 total), and COO Dragan Popovic ($4,655,816 total). The filing details plans for IPO equity awards under the 2026 Equity Incentive Plan, including stock options for NEOs covering 1,660,078 shares for Sell, 1,649,853 for Gross, and 1,154,897 for Popovic (based on $17.50/share midpoint), and approximately $1,400,000 in RSUs for non-employee directors. It also outlines board committees and compensation policies with no reported interlocks or insider participation issues.

• ·Annual base salaries: J. Clay Sell $612,000, Daniel Gross $550,000, Dragan Popovic $450,000.
• ·Compensation and Culture Committee: Kathleen W. Hyle, Allyson Satin, Gregory J. Goff (chair).
• ·Nominating and Corporate Governance Committee: Gregory J. Goff (chair), Christopher F. Ginther, Michael J. Wallace.
• ·No compensation committee interlocks or insider participation.
• ·Company to adopt Code of Business Conduct and Ethics and clawback policy compliant with Nasdaq standards.

20-04-2026

Neogen Corporation announced plans to host two investor tours of its Petrifilm manufacturing facility in Lansing, Michigan on April 20 and 21, 2026, under Regulation FD Disclosure. The company has successfully completed multiple operational qualifications for certain Petrifilm single kit units (SKUs) and is proceeding with performance qualifications as part of its overall validation efforts, with details to be shared during the tours.

• ·Facility address: 620 Lesher Place, Lansing, Michigan 48912
• ·Filed under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)

20-04-2026

enCore Energy Corp. appointed Richard H. Little as Chief Executive Officer and Director, replacing Robert Willette effective immediately, while founder William M. Sheriff returned as Executive Chair. The Board outlined a renewal program emphasizing cost management, permitting acceleration, and asset development amid acknowledged challenges like permitting delays and operational inefficiencies. A corporate update conference call is scheduled for April 23, 2026, at 11 AM ET.

• ·Conference call details: Thursday, April 23, 2026 at 11 AM ET via https://app.webinar.net/OlMrE49n2DW
• ·Renewal commitments: enhanced shareholder communications, cost management and efficiency, timely permitting, aggressive asset development, accretive M&A

20-04-2026

Dauch Corporation (formerly American Axle & Manufacturing Holdings Inc.) filed a supplement to its March 19, 2026 proxy statement for the April 30, 2026 annual stockholder meeting, addressing ISS's recommendation against Proposal 3 to amend the 2018 Omnibus Incentive Plan by increasing available shares by 9,000,000. On April 13, 2026, the Compensation Committee approved a post-exercise holding requirement policy for named executive officers to counter ISS concerns regarding the absence of such a policy. The Board reiterates its recommendation to vote FOR the Plan Amendment.

• ·Proxy Statement filed with SEC on March 19, 2026
• ·Plan Amendment approved by Board on February 4, 2026
• ·Annual meeting scheduled for April 30, 2026 at 8:00 a.m. EST
• ·Post-exercise holding period: 12 months or earlier upon change in control, death, disability, or no longer NEO
• ·Institutional Shareholder Services (ISS) issued negative recommendation on Plan Amendment

20-04-2026

Bicycle Therapeutics plc announced on April 20, 2026, via Form 8-K, the issuance of a press release providing updates on its nuzefatide pevedotin program and EphA2 pipeline. The press release is furnished as Exhibit 99.1. No financial or quantitative performance metrics, including any period-over-period comparisons, were disclosed in the filing.

20-04-2026

SmartFinancial reported Q1 2026 net income of $13.7 million ($0.81 per diluted share), unchanged QoQ from $13.7 million but up from $11.3 million YoY, supported by net interest income of $45.9 million (up from $45.1 million QoQ) and NIM expansion to 3.48% from 3.38%. Strong organic loan growth of $155 million (14% annualized QoQ) and core deposit growth of $95 million (7% annualized QoQ) were highlights, however noninterest income fell $0.3 million to $7.9 million, noninterest expense rose $0.4 million to $32.9 million, and nonperforming loans increased to 0.27% of total loans from 0.22%.

• ·Conference call scheduled for April 20, 2026 at 10:00 a.m. ET.
• ·Tangible book value per common share $27.33 at Mar 31 2026 (up from $26.85).
• ·Unfunded commitment liability $4.5M at Mar 31 2026 (up from $3.6M).

20-04-2026

OpenText Corporation announced on April 20, 2026, that James McGourlay transitions from Interim CEO to President, Chief Client Officer, reporting to new CEO Ayman Antoun, to focus on client experience, professional services, renewals, and cloud migration. Simultaneously, Paul Duggan is stepping down from President, Chief Customer Officer to Executive Vice President, Special Advisor, with his full departure from the company on July 1, 2026. This leadership transition aims to reinforce client outcomes and growth in core products and enterprise AI data management.

• ·James McGourlay previously served as Interim CEO and held senior roles in sales, customer operations, and executive management.
• ·Paul Duggan will remain on the Executive Leadership Team until July 1, 2026.
• ·OpenText trades on NASDAQ: OTEX and TSX: OTEX.

20-04-2026

On April 20, 2026, Stanley Black & Decker, Inc. announced via Form 8-K that it does not expect recent changes to the Section 232 tariff regime to have a material impact on its full-year guidance. The company's press release is attached as Exhibit 99.1 and incorporated by reference. Forward-looking statements are included with standard cautions about risks and uncertainties.

20-04-2026

Centrus Energy Corp. (NYSE: LEU) selected Geiger Brothers, Inc. as the construction contractor for its multi-billion-dollar uranium enrichment plant expansion in Piketon, Ohio, with Fluor Corporation serving as the EPC contractor to deploy thousands of additional AC100M centrifuges for LEU and HALEU production. This partnership leverages Geiger Brothers' prior experience on Centrus' HALEU cascade and 2013 LEU demonstration, aiming for cost efficiencies while supporting a $2.3 billion commercial LEU backlog and at least 12 metric tons per year of HALEU capacity. Centrifuge manufacturing for the expansion launched in December 2025 at the Oak Ridge, Tennessee facility.

• ·Geiger Brothers founded in 1909, headquartered in Jackson, Ohio, and employee-owned.
• ·Previous Geiger Brothers involvement: existing HALEU cascade and 2013 LEU demonstration cascade.
• ·Equivalent of more than 7 billion tons of coal in fuel provided since 1998.